Christine Spencer outlines her study investigating the effect of diet and supplements on gut microbiota and response to anti-PD-1 therapy in patients with metastatic melanoma, and discusses how the findings may be relevant to other tumor types (3:43).
You Might Also Like...
VISTA Checkpoint Implicated in Pancreatic Cancer Immunotherapy Resistance
The ASCO Post | April 10, 2019
AACR 2019 Roundup: Notes from a Weekend of Early Stage Cancer Results
Xconomy | April 3, 2019